With 36 Blue Cross Blue Shield healthcare companies as limited partners, Blue Venture Fund manages a complex set of stakeholders. Head of fund John Banta has created a robust operational machinery and a cast-iron investment focus to make this work.
The Blue Venture Fund (BVF) represents one of the most complex architectural challenges in corporate venturing. Rather than serving a single corporation, the fund is a unique collaboration between the Blue Cross Blue Shield Association, Sandbox Industries and over 36 independent Blue Cross Blue Shield (BCBS) companies and their affiliates. Together, these plans cover one in three Americans, creating a sprawling, decentralised ecosystem that would baffle most traditional venture capitalists.
When John Banta joined as president and managing director 14 years ago, the unit was young but off to a strong start. Today, with $1.5bn under management across five funds and a clinical fund, BVF has become a blueprint for how to professionalise the "multi-LP" corporate venture model.
Normalising the unconventional structure
Banta, a former investment banker, entrepreneur and tech transfer general partner, describes himself as oddly familiar with complex stakeholder sets. When he arrived, the fund already utilised a general partner-limited partner (GPLP) structure—a rarity for corporate venture capital at the time, but there was room to evolve beyond other structural aspects typical of corporate setups.
Our annual industry survey tracks metrics such as fund and team size, salary and performance across the corporate venture sector globally.
Add your data and receive a free copy of the resulting benchmarking report. All data is anonymised.
By adopting frameworks of the independent venture world, in a manner that fit a programme "owned and governed" by the participating plans, BVF could better navigate the dual requirements of retaining top-tier investment talent through appropriate compensation while remaining tethered to the strategic needs of its 36 independent sponsors. This structural rigour allowed the fund to grow from a $116m Fund I to a massive platform that facilitates 125 investment assessments for every one deal it completes.
Lesson: To attract professional talent and scale effectively, CVCs should adopt the structural norms of independent VC while carefully tweaking governance to satisfy corporate stakeholders.
Finding the "Blue angle" in a stage-agnostic portfolio
One of BVF’s most distinctive strategies is its "stage-agnostic" approach, investing in everything from seed rounds to buyouts. While many CVCs limit themselves to early-stage "innovation scouting," Banta and the BVF team balance earlier-stage work with the stability of mature businesses that carry less risk and a more actionable development path within the BCBS system.
The Blue Venture Fund team coined the concept of "pointillism" to describe this: looking at what is incrementally relevant today while remaining cognisant of the edges of the innovation landscape. This allows the fund to back companies like Nest, which developed a new model for serving vulnerable Medicaid populations through integrated virtual and in-person primary, behavioral and maternity care – creatively addressing a problem "nobody else has found a way to solve".
Maija Palmer
Maija Palmer is editor of Global Venturing and puts together the weekly email newsletter (sign up here for free).
